Browse > Article
http://dx.doi.org/10.1080/19768354.2011.630411

Maturation and migration of dendritic cells upon stimulation with heat-killed tumor cells  

Kim, Hyo-Jeong (Department of Bioscience and Biotechnology, Sejong University)
Yoon, Taek-Joon (Department of Food & Nutrition, Yuhan College)
Lee, Sung-Won (Department of Bioscience and Biotechnology, Sejong University)
Yun, Dae-Sun (Department of Bioscience and Biotechnology, Sejong University)
Kim, Ji-Yeon (School of Life Science & Biotechnology, Korea University)
Shin, Kwang-Soon (Department of Food & Biotechnology, Kyonggi University)
Park, Se-Ho (School of Life Science & Biotechnology, Korea University)
Hong, Seok-Mann (Department of Bioscience and Biotechnology, Sejong University)
Publication Information
Animal cells and systems / v.16, no.3, 2012 , pp. 215-223 More about this Journal
Abstract
Recently it has been reported that immunization with heat-killed tumor cells (HK vaccine) induces anti-tumor immune responses in mice. To investigate how HKvaccine elicits anti-tumor specific adaptive immunity, we examined the effect of HK vaccination on innate immune cells such as dendritic cells (DCs), which are essential for the generation of adaptive immunity. Upon stimulation with HK vaccine, DCs matured to promote not only the upregulation of co-stimulatory molecules but also secretion of cytokine IL12. Furthermore, HK vaccine-treated DCs migrated more efficiently to draining lymph nodes compared with untreated ones. Taken together, HK vaccine can be useful as an adjuvant to activate DCs for anti-tumor immune responses.
Keywords
heat-killed tumor cells; dendritic cells; interleukin 12;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Taraban VY, Rowley TF, Al-Shamkhani A. 2004. Cutting edge:a critical role for CD70 in CD8 T cell priming by CD40-licensed APCs. J Immunol. 173:6542-6546.   DOI
2 Van Deusen KE, Rajapakse R, Bullock TN. 2010. CD70 expression by dendritic cells plays a critical role in the immunogenicity of CD40-independent, CD4- T celldependent, licensed CD8- T cell responses. J Leukoc Biol. 87:477-485.   DOI
3 van Duin D, Medzhitov R, Shaw AC. 2006. Triggering TLR signaling in vaccination. Trends Immunol. 27:49-55.   DOI
4 Villadangos JA, Schnorrer P. 2007. Intrinsic and cooperative antigen-presenting functions of dendritic-cell subsets in vivo. Nat Rev Immunol. 7:543-555.   DOI
5 Wan H, Dupasquier M. 2005. Dendritic cells in vivo and in vitro. Cell Mol Immunol. 2:28-35.
6 Yoon TJ, Kim JY, Kim H, Hong C, Lee H, Lee CK, Lee KH, Hong S, Park SH. 2008. Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp Mol Med. 40: 130-144.   DOI
7 ImW, Kim H, Yun D, Seo SY, Park SH, Locksley RM, Hong S. 2005. Cytokine reporter mouse system for screening novel IL12/23 p40-inducing compounds. Mol Cells. 20:288-296.
8 Iwasaki A, Medzhitov R. 2004. Toll-like receptor control of the adaptive immune responses. Nat Immunol. 5: 987-995.   DOI
9 Jin MS, Lee J-O. 2009. Ligand recognition by the Toll-like receptor family. Anim Cells Syst. 13:1-8.   DOI
10 Kushwah R, Hu J. 2011. Complexity of dendritic cell subsets and their function in the host immune system. Immunology. 133:409-419.   DOI
11 Langrish CL, McKenzie BS, Wilson NJ, de Waal Malefyt R, Kastelein RA, Cua DJ. 2004. IL-12 and IL-23:master regulators of innate and adaptive immunity. Immunol Rev. 202:96-105.   DOI
12 Liu Y-J. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell. 106: 259-262.   DOI
13 Mackey MF, Gunn JR, Maliszewsky C, Kikutani H, Noelle RJ, Barth RJ Jr. 1998. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J Immunol. 161:2094-2098.
14 Ribas A, Butterfield LH, Glaspy JA, Economou JS. 2003. Current developments in cancer vaccines and cellular immunotherapy. J Clin Oncol. 21:2415-2432.   DOI
15 McDonnell AM, Robinson BW, Currie AJ. 2010. Tumor antigen cross-presentation and the dendritic cell: where it all begins? Clin Dev Immunol. 2010:539519.
16 Melcher A, Todryk S, Hardwick N, Ford M, Jacobson M, Vile RG. 1998. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med. 4:581-587.   DOI
17 Reinhardt RL, Hong S, Kang S-J, Wang Z-e, Locksley RM. 2006. Visualization of IL-12/23p40 in vivo reveals immunostimulatory dendritic cell migrants that promote Th1 differentiation. J Immunol. 177:1618-1627.   DOI
18 Ridge JP, Di Rosa F, Matzinger P. 1998. A conditioned dendritic cell can be a temporal bridge between a CD4- T-helper and a T-killer cell. Nature. 393:474-478.   DOI
19 Riol-Blanco L, Sancnez-Sanchez N. 2005. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol. 174:4070-4080.   DOI
20 Schuster M, Nechansky A, Kircheis R. 2006. Cancer immunotherapy. Biotechnol J. 1:138-147.   DOI
21 Shi H, Cao T, Connolly JE, Monnet L, Bennett L, Chapel S, Bagnis C, Mannoni P, Davoust J, Palucka AK, et al. 2006. Hyperthermia enhances CTL cross-priming. J Immunol. 176:2134-2141.   DOI
22 Shortman K, Lahoud MH, Caminschi I. 2009. Improving vaccines by targeting antigens to dendritic cells. Exp Mol Med. 41:61-66.   DOI
23 Shortman K, Liu YJ. 2002. Mouse and human dendritic cell subtypes. Nat Rev Immunol. 2:151-161.   DOI
24 Bullock TN, Yagita H. 2005. Induction of CD70 on dendritic cells through CD40 or TLR stimulation contributes to the development of CD8-T cell responses in the absence of CD4- T cells. J Immunol. 174:710.   DOI
25 Strome SE, Voss S,Wilcox R,Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, et al. 2002. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res. 62:1884-1889.
26 Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature. 392:245-252.   DOI
27 Brasel K, De Smedt T, Smith JL, Maliszewski CR. 2000. Generation of murine dendritic cells from flt3-ligandsupplemented bone marrow cultures. Blood. 96: 3029-3039.
28 Colonna M, Pulendran B, Iwasaki A. 2006. Dednritic cells at the host-pathogen interface. Nat Immunol. 7:117-120.   DOI
29 Gilliet M, Boonstra A, Paturel C, Antonenko S, Xu XL, Trinchieri G, O'Garra A, Liu YJ. 2002. The development of murine plasmacytoid dendritic cell precursors is differentially regulated by FLT3-ligand and granulocyte/macrophage colony-stimulating factor. J Exp Med. 195:953-958.   DOI
30 Hoebe K, Janssen E, Beutler B. 2004. The interface between innate and adaptive immunity. Nat Immunol. 5:971-974.
31 Hurwitz AA, Kwon ED, van Elsas A. 2000. Costimulatory wars: the tumor menace. Curr Opin Immunol. 12: 589-596.   DOI